735 related articles for article (PubMed ID: 33994251)
1. Natural flavonol fisetin attenuated hyperuricemic nephropathy via inhibiting IL-6/JAK2/STAT3 and TGF-β/SMAD3 signaling.
Ren Q; Tao S; Guo F; Wang B; Yang L; Ma L; Fu P
Phytomedicine; 2021 Jul; 87():153552. PubMed ID: 33994251
[TBL] [Abstract][Full Text] [Related]
2. Ethanol extract of Liriodendron chinense (Hemsl.) Sarg barks attenuates hyperuricemic nephropathy by inhibiting renal fibrosis and inflammation in mice.
Pan J; Zhang C; Shi M; Guo F; Liu J; Li L; Ren Q; Tao S; Tang M; Ye H; Ma L; Fu P
J Ethnopharmacol; 2021 Jan; 264():113278. PubMed ID: 32841699
[TBL] [Abstract][Full Text] [Related]
3. Berberrubine attenuates potassium oxonate- and hypoxanthine-induced hyperuricemia by regulating urate transporters and JAK2/STAT3 signaling pathway.
Lin G; Yu Q; Xu L; Huang Z; Mai L; Jiang L; Su Z; Xie J; Li Y; Liu Y; Lin Z; Chen J
Eur J Pharmacol; 2021 Dec; 912():174592. PubMed ID: 34699754
[TBL] [Abstract][Full Text] [Related]
4. Astilbin improves potassium oxonate-induced hyperuricemia and kidney injury through regulating oxidative stress and inflammation response in mice.
Wang M; Zhao J; Zhang N; Chen J
Biomed Pharmacother; 2016 Oct; 83():975-988. PubMed ID: 27522260
[TBL] [Abstract][Full Text] [Related]
5. Apigenin ameliorates hyperuricemic nephropathy by inhibiting URAT1 and GLUT9 and relieving renal fibrosis via the Wnt/β-catenin pathway.
Li Y; Zhao Z; Luo J; Jiang Y; Li L; Chen Y; Zhang L; Huang Q; Cao Y; Zhou P; Wu T; Pang J
Phytomedicine; 2021 Jul; 87():153585. PubMed ID: 34044255
[TBL] [Abstract][Full Text] [Related]
6. Pharmacological inhibition of fatty acid-binding protein 4 alleviated kidney inflammation and fibrosis in hyperuricemic nephropathy.
Shi M; Guo F; Liao D; Huang R; Feng Y; Zeng X; Ma L; Fu P
Eur J Pharmacol; 2020 Nov; 887():173570. PubMed ID: 32949603
[TBL] [Abstract][Full Text] [Related]
7. Pterostilbene, a bioactive component of blueberries, alleviates renal fibrosis in a severe mouse model of hyperuricemic nephropathy.
Pan J; Shi M; Li L; Liu J; Guo F; Feng Y; Ma L; Fu P
Biomed Pharmacother; 2019 Jan; 109():1802-1808. PubMed ID: 30551434
[TBL] [Abstract][Full Text] [Related]
8. Pharmacologic targeting ERK1/2 attenuates the development and progression of hyperuricemic nephropathy in rats.
Liu N; Xu L; Shi Y; Fang L; Gu H; Wang H; Ding X; Zhuang S
Oncotarget; 2017 May; 8(20):33807-33826. PubMed ID: 28442634
[TBL] [Abstract][Full Text] [Related]
9. Eurycoma longifolia alkaloid components ameliorate hyperuricemic nephropathy via regulating serum uric acid level and relieving inflammatory reaction.
Wang D; Liu L; Li K; Cao H; Liu M; Chen Q; Wu Y; Zhang Y; Wang T
J Nat Med; 2023 Sep; 77(4):867-879. PubMed ID: 37433989
[TBL] [Abstract][Full Text] [Related]
10. Natural Flavonoid Pectolinarigenin Alleviated Hyperuricemic Nephropathy via Suppressing TGFβ/SMAD3 and JAK2/STAT3 Signaling Pathways.
Ren Q; Wang B; Guo F; Huang R; Tan Z; Ma L; Fu P
Front Pharmacol; 2021; 12():792139. PubMed ID: 35153751
[TBL] [Abstract][Full Text] [Related]
11. Fuling-Zexie formula attenuates hyperuricemia-induced nephropathy and inhibits JAK2/STAT3 signaling and NLRP3 inflammasome activation in mice.
Lu M; Yin J; Xu T; Dai X; Liu T; Zhang Y; Wang S; Liu Y; Shi H; Zhang Y; Mo F; Sukhorukov V; Orekhov AN; Gao S; Wang L; Zhang D
J Ethnopharmacol; 2024 Jan; 319(Pt 2):117262. PubMed ID: 37788785
[TBL] [Abstract][Full Text] [Related]
12. Hypouricemic and Nephroprotective Effects of Emodinol in Oxonate-Induced Hyperuricemic Mice are Mediated by Organic Ion Transporters and OIT3.
Hui W; Yongliang Y; Yongde C; Guo L; Li L; Zhonglin Y; Hui J; Qinghua H
Planta Med; 2016 Mar; 82(4):289-297. PubMed ID: 26584455
[TBL] [Abstract][Full Text] [Related]
13. Fisetin ameliorates fibrotic kidney disease in mice via inhibiting ACSL4-mediated tubular ferroptosis.
Wang B; Yang LN; Yang LT; Liang Y; Guo F; Fu P; Ma L
Acta Pharmacol Sin; 2024 Jan; 45(1):150-165. PubMed ID: 37696989
[TBL] [Abstract][Full Text] [Related]
14. Paeonia × suffruticosa Andrews leaf extract and its main component apigenin 7-O-glucoside ameliorate hyperuricemia by inhibiting xanthine oxidase activity and regulating renal urate transporters.
Zhang Y; Li Y; Li C; Zhao Y; Xu L; Ma S; Lin F; Xie Y; An J; Wang S
Phytomedicine; 2023 Sep; 118():154957. PubMed ID: 37478683
[TBL] [Abstract][Full Text] [Related]
15. Qi-Zhu-Xie-Zhuo-Fang reduces serum uric acid levels and ameliorates renal fibrosis in hyperuricemic nephropathy rats.
Huijuan W; Xiaoxu C; Rui S; Xinghui L; Beibei T; Jianchun M
Biomed Pharmacother; 2017 Jul; 91():358-365. PubMed ID: 28463799
[TBL] [Abstract][Full Text] [Related]
16. Zishen Qingre Tongluo Formula Improves Renal Fatty Acid Oxidation and Alleviated Fibrosis via the Regulation of the TGF-
Liu P; Wang C; Wang Y; Zhang H; Liu B; Qiu X
Biomed Res Int; 2021; 2021():2793823. PubMed ID: 34938805
[TBL] [Abstract][Full Text] [Related]
17. Simiao San alleviates hyperuricemia and kidney inflammation by inhibiting NLRP3 inflammasome and JAK2/STAT3 signaling in hyperuricemia mice.
Zhang Y; Wang S; Dai X; Liu T; Liu Y; Shi H; Yin J; Xu T; Zhang Y; Zhao D; Sukhorukov V; Orekhov AN; Gao S; Wang L; Zhang D
J Ethnopharmacol; 2023 Aug; 312():116530. PubMed ID: 37098372
[TBL] [Abstract][Full Text] [Related]
18. Siwu decoction attenuates oxonate-induced hyperuricemia and kidney inflammation in mice.
Wang R; Ma CH; Zhou F; Kong LD
Chin J Nat Med; 2016 Jul; 14(7):499-507. PubMed ID: 27507200
[TBL] [Abstract][Full Text] [Related]
19. Treatment with a PPAR-γ Agonist Protects Against Hyperuricemic Nephropathy in a Rat Model.
Wang X; Deng J; Xiong C; Chen H; Zhou Q; Xia Y; Shao X; Zou H
Drug Des Devel Ther; 2020; 14():2221-2233. PubMed ID: 32606592
[TBL] [Abstract][Full Text] [Related]
20. Wuling San protects kidney dysfunction by inhibiting renal TLR4/MyD88 signaling and NLRP3 inflammasome activation in high fructose-induced hyperuricemic mice.
Yang Y; Zhang DM; Liu JH; Hu LS; Xue QC; Ding XQ; Kong LD
J Ethnopharmacol; 2015 Jul; 169():49-59. PubMed ID: 25914040
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
